Source: Health Canada shortage reports · Updated Jul 13, 2026
Also sold as: Pazeo, Patanol, Pataday
Some Olopatadine products are in shortage in Canada (5 of 11 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
An antihistamine used to relieve allergy symptoms in the eyes or nose.
Products affected
5 / 11
In shortage since
Sep 1, 2018
Reports on file
33
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
JAMP-OLOPATADINE
0.1% · SOLUTION · JAMP PHARMA CORPORATION
DIN 02458411 · since Aug 7, 2025, est. end Mar 31, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-OLOPATADINE
0.2% · SOLUTION · APOTEX INC
DIN 02402823 · since Mar 26, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-OLOPATADINE
0.1% · SOLUTION · APOTEX INC
DIN 02305054 · since Jun 1, 2020, no end estimate · Disruption of the manufacture of the drug.
Active shortage
ACT OLOPATADINE 0.1%
0.1% · SOLUTION · ACTAVIS PHARMA COMPANY
DIN 02403986 · since Sep 1, 2018, no end estimate · Disruption of the manufacture of the drug.
Active shortage
ACT OLOPATADINE 0.2%
0.2% · SOLUTION · ACTAVIS PHARMA COMPANY
DIN 02404095 · since Sep 1, 2018, no end estimate · Disruption of the manufacture of the drug.
Anticipated
SANDOZ OLOPATADINE 0.2%
0.2% · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02420171 · Demand increase for the drug.
Resolved
OLOPATADINE 0.2%
0.2% · SOLUTION · SANIS HEALTH INC
DIN 02541653 · ended Dec 10, 2025 · Disruption of the manufacture of the drug.
Resolved
OLOPATADINE 0.2%
0.2% · SOLUTION · SANIS HEALTH INC
DIN 02541653 · ended Nov 7, 2025 · Disruption of the manufacture of the drug.
Resolved
SANDOZ OLOPATADINE 0.2%
0.2% · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02420171 · ended Oct 31, 2025 · Disruption of the manufacture of the drug.
DIN 02362171 · ended Oct 10, 2025 · Demand increase for the drug.
Resolved
SANDOZ OLOPATADINE 0.2%
0.2% · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02420171 · ended Aug 4, 2025 · Disruption of the manufacture of the drug.
Resolved
JAMP-OLOPATADINE
0.1% · SOLUTION · JAMP PHARMA CORPORATION
DIN 02458411 · ended Jul 31, 2025 · Increase in demand / under allocation
Showing 12 of 33 reports. All reports are on file with Health Canada.
What's happening
Olopatadine is currently affected by 5 active shortage reports filed with Health Canada by JAMP PHARMA CORPORATION, APOTEX INC, ACTAVIS PHARMA COMPANY.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Olopatadine is classified under “DECONGESTANTS AND ANTIALLERGICS” (ATC S01GX).
Recent changes
Jul 13, 2026
New report filed
Common questions
What is Olopatadine used for?
An antihistamine used to relieve allergy symptoms in the eyes or nose.
When will Olopatadine be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Olopatadine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.